Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fanconi Anemia, Complementation Group D1 × liposomal doxorubicin × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Classical hematology 1

Conditions

Ovarian Neoplasms 1 Fanconi Anemia, Complementation Group D1 1

Interventions

olaparib 7 Carboplatin 2 talazoparib 1 pembrolizumab 1 liposomal doxorubicin 1 iniparib 1 Trabectedin 1 Surveys and Questionnaires 1 Secretin 1 Paclitaxel 1 Genotype 1 Genetic Counseling 1 Demography 1 Data Collection 1 Counseling 1 Biopsy, Fine-Needle 1 ABT-767 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00628251 2019-12-05

ICEBERG 3

AstraZeneca

Phase 2 Completed

97 enrolled 22 charts

Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡